Evaluation of a commercially available radioimmunoassay and species-specific ELISAs for measurement of high concentrations of insulin in equine serum

Kate E. Borer-Weir Department of Veterinary Clinical Sciences, Royal Veterinary College, North Mymms, Hatfield, Hertfordshire, AL9 7TA, England.

Search for other papers by Kate E. Borer-Weir in
Current site
Google Scholar
PubMed
Close
 BVSc, PhD
,
Simon R. Bailey Faculty of Veterinary Science, University of Melbourne, Melbourne, VIC 3031, Australia.

Search for other papers by Simon R. Bailey in
Current site
Google Scholar
PubMed
Close
 BVMS, PhD
,
Nicola J. Menzies-Gow Department of Veterinary Clinical Sciences, Royal Veterinary College, North Mymms, Hatfield, Hertfordshire, AL9 7TA, England.

Search for other papers by Nicola J. Menzies-Gow in
Current site
Google Scholar
PubMed
Close
 VetMB, PhD
,
Patricia A. Harris Waltham Centre For Pet Nutrition, Freeby Ln, Waltham-on-the-Wolds, Leicestershire, LE14 4RT, England.

Search for other papers by Patricia A. Harris in
Current site
Google Scholar
PubMed
Close
 VetMB, PhD
, and
Jonathan Elliott Department of Veterinary Basic Sciences, Royal Veterinary College, University of London, London, NW1 0TU, England.

Search for other papers by Jonathan Elliott in
Current site
Google Scholar
PubMed
Close
 VetMB, PhD

Abstract

Objective—To evaluate a human radioimmunoassay (RIA) and equine and high-range porcine (hrp) species-specific ELISAs for the measurement of high serum insulin concentrations in ponies.

Samples—Serum samples from 12 healthy nonobese ponies (7 clinically normal and 5 laminitis prone; 13 to 26 years of age; 11 mares and 1 gelding) before and after glucose, insulin, and dexamethasone administration.

Procedures—Intra-and interassay repeatability, freeze-thaw stability, dilutional parallelism, and assay agreement were assessed.

Results—Assay detection limits were as follows: RIA, < 389 μU/mL; equine ELISA, < 175 μU/mL; and hrp ELISA, 293 to 8,775 μU/mL. Mean ± SD intra- and interassay repeatability were respectively as follows: RIA, 6.5 ± 5.1 % and 74 ± 3.4%; equine ELISA, 10.6 ± 11.0% and 9.0 ± 4.6%; and hrp ELISA, 19.9 ± 172% and 173 ± 16.6%. Freezing and thawing affected measured concentrations. Dilutional parallelism in the RIA was only evident when insulin-depleted equine serum was used as a diluent (percentage recovery, 95.7 ± 274%); in the ELISAs, dilutional parallelism was observed when a zero calibrator was used. Agreement between RIA and equine ELISA results was good for samples containing concentrations < 175 μU of insulin/mL (bias, −18.5 ± 25.5 μU/mL; higher in RIA). At higher concentrations, assay agreement was poor between RIA and equine ELISA results (bias, −185.3 ± 98.7 μU/mL) and between RIA and hrp ELISA results (bias, 25.3 ± 183.0 μU/mL).

Conclusions and Clinical Relevance—Agreement among results of the 3 assays was variable, and dilutional parallelism was only evident with the RIA when insulin-depleted equine serum was tested. Caution is recommended when evaluating high insulin concentrations measured with the RIA or ELISAs.

Abstract

Objective—To evaluate a human radioimmunoassay (RIA) and equine and high-range porcine (hrp) species-specific ELISAs for the measurement of high serum insulin concentrations in ponies.

Samples—Serum samples from 12 healthy nonobese ponies (7 clinically normal and 5 laminitis prone; 13 to 26 years of age; 11 mares and 1 gelding) before and after glucose, insulin, and dexamethasone administration.

Procedures—Intra-and interassay repeatability, freeze-thaw stability, dilutional parallelism, and assay agreement were assessed.

Results—Assay detection limits were as follows: RIA, < 389 μU/mL; equine ELISA, < 175 μU/mL; and hrp ELISA, 293 to 8,775 μU/mL. Mean ± SD intra- and interassay repeatability were respectively as follows: RIA, 6.5 ± 5.1 % and 74 ± 3.4%; equine ELISA, 10.6 ± 11.0% and 9.0 ± 4.6%; and hrp ELISA, 19.9 ± 172% and 173 ± 16.6%. Freezing and thawing affected measured concentrations. Dilutional parallelism in the RIA was only evident when insulin-depleted equine serum was used as a diluent (percentage recovery, 95.7 ± 274%); in the ELISAs, dilutional parallelism was observed when a zero calibrator was used. Agreement between RIA and equine ELISA results was good for samples containing concentrations < 175 μU of insulin/mL (bias, −18.5 ± 25.5 μU/mL; higher in RIA). At higher concentrations, assay agreement was poor between RIA and equine ELISA results (bias, −185.3 ± 98.7 μU/mL) and between RIA and hrp ELISA results (bias, 25.3 ± 183.0 μU/mL).

Conclusions and Clinical Relevance—Agreement among results of the 3 assays was variable, and dilutional parallelism was only evident with the RIA when insulin-depleted equine serum was tested. Caution is recommended when evaluating high insulin concentrations measured with the RIA or ELISAs.

All Time Past Year Past 30 Days
Abstract Views 55 0 0
Full Text Views 2158 1503 17
PDF Downloads 311 169 7
Advertisement